about
Protein Kinase A-Dependent Step(s) in Hepatitis C Virus Entry and InfectivityCannabinoid receptor systems: therapeutic targets for tumour intervention.Biological applications of the receptor mimetic peptide mastoparan.The many futures for cell-penetrating peptides: how soon is now?Can RNAi-mediated hsp90α knockdown in combination with 17-AAG be a therapy for glioma?Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions.Cell penetrating peptide-mediated transport enables the regulated secretion of accumulated cargoes from mast cells.Peptide-based glioma-targeted drug delivery vector gHoPe2.Applications of cell-penetrating peptides as signal transduction modulators for the selective induction of apoptosis.Characterization of bioactive cell penetrating peptides from human cytochrome c: protein mimicry and the development of a novel apoptogenic agent.Mitoparan and target-selective chimeric analogues: membrane translocation and intracellular redistribution induces mitochondrial apoptosis.Intracellular translocation of the decapeptide carboxyl terminal of Gi3 alpha induces the dual phosphorylation of p42/p44 MAP kinases.Charge delocalisation and the design of novel mastoparan analogues: enhanced cytotoxicity and secretory efficacy of [Lys5, Lys8, Aib10]MP.Intracellular delivery of bioactive peptides to RBL-2H3 cells induces beta-hexosaminidase secretion and phospholipase D activation.Protein Mimicry and the Design of Bioactive Cell-Penetrating Peptides.Critical evaluation of ECV304 as a human endothelial cell model defined by genetic analysis and functional responses: a comparison with the human bladder cancer derived epithelial cell line T24/83.Cell-penetrating peptides, targeting the regulation of store-operated channels, slow decay of the progesterone-induced [Ca2+]i signal in human sperm.Intracellular translocation and differential accumulation of cell-penetrating peptides in bovine spermatozoa: evaluation of efficient delivery vectors that do not compromise human sperm motility.Group III metabotropic glutamate receptor activation inhibits Ca2+ influx and nitric oxide synthase activity in bone marrow stromal cells.Bioportide: an emergent concept of bioactive cell-penetrating peptides.Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates.Enantiomer-Specific Bioactivities of Peptidomimetic Analogues of Mastoparan and Mitoparan: Characterization of Inverso Mastoparan as a Highly Efficient Cell Penetrating Peptide
P50
Q27486784-EB5B02D3-735B-4768-BE3C-3749533B0B7AQ35593944-2952ADCA-E790-4327-A14A-43AB7FF4AB3DQ36683707-923F1467-D79E-421C-B31B-0AE6AF8AB18EQ36883955-161080C3-B98C-40AF-A4A8-6F1B5B5FF916Q37043720-1D07473E-6AC8-42B2-BDC4-154661CF5521Q38563691-007D07B3-7135-45F9-B257-1B6B742A3309Q38912098-806E8A41-C41F-402C-A1A6-CA01814B8F01Q39204672-4B0BD1E0-6F41-4370-8A8A-E4947FF2526AQ39635449-D7BFFF21-7798-4C45-8EA0-314D45BB39A8Q39675792-B30D72D8-AE20-417A-BD70-BC712166B865Q40014187-82CAD256-5478-44DA-A56C-B340BC2F5BAFQ40410285-99360088-94B7-4F12-8976-3C6CDE3338EBQ40535049-72D62BBE-28BD-42E3-A8EB-F81C9647AB42Q40609608-71966B4E-FA21-4A1A-9CE6-67455C1FC754Q40706322-FA813DBE-B6DB-40F0-89FB-B36A1DCF43F2Q40903073-ED9FB9C1-9D4E-4C25-A66E-3EA65DFBBAE7Q41542733-FE25E4E7-CDCD-42A7-A339-D8BAB3986A5DQ42094009-0412BDEE-4501-4C34-B1AE-1FF832944BE5Q42476218-F2AF776C-FE63-40A9-95F1-E70B0172302FQ42979619-A98B4938-5D77-4E92-BFD7-2DDE050EF0D1Q50906666-A930B5F3-F786-4CC4-8E2D-8C24A81C5AEFQ60589686-2BA48164-F6E5-4388-8B57-F1A61A55BF96
P50
description
onderzoeker
@nl
pharmacologist
@en
name
Sarah Jones
@ast
Sarah Jones
@en
Sarah Jones
@es
Sarah Jones
@sl
سارة جونز
@ar
type
label
Sarah Jones
@ast
Sarah Jones
@en
Sarah Jones
@es
Sarah Jones
@sl
سارة جونز
@ar
prefLabel
Sarah Jones
@ast
Sarah Jones
@en
Sarah Jones
@es
Sarah Jones
@sl
سارة جونز
@ar
P106
P21
P31
P496
0000-0003-4951-8647